Identification of Volume of Distribution for 239Pu in Rats

Area of Science:

• Pharmacokinetics
• Toxicology
• Radiochemistry

Background:

• Physiologically-based pharmacokinetic (PBPK) models are essential for understanding radionuclide behavior.
• Accurate biokinetic models are needed for internal dosimetry.
• Plutonium's distribution in the body requires precise parameterization.

Purpose of the Study:

• To identify the volume of distribution (VD) of plutonium in rats.
• To establish a VD value consistent with plutonium's known biological behavior.
• To inform the development of PBPK models for plutonium.

Main Methods:

• Analysis of two distinct rat datasets involving intravenous 239Pu4+-citrate injection.
• Examination of data from Durbin and colleagues.
• Evaluation of studies conducted by Lovelace Respiratory Research Institute (LRRI).

Main Results:

• VD values derived from Durbin's data aligned with plutonium's known biological behavior.
• VD values from LRRI data were inconsistent with plutonium's known behavior.
• VD time profiles from LRRI data may still be valuable for PBPK modeling.

Conclusions:

• The VD derived from Durbin's data supports PBPK model development for plutonium.
• Discrepancies in LRRI data highlight the need for careful data selection in PBPK modeling.
• Accurate VD determination is critical for validating internal dosimetry models.